nVerses Capital »

Ptc Therapeutics I shares owned by nVerses Capital

Quarter-by-quarter ownership of Ptc Therapeutics I (PTCT) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Ptc Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Ptc Therapeutics I held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ptc Therapeutics I by nVerses Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $367k 4.5k 81.57
2024-03-31 $58k 2.0k 29.09

More positions owned by nVerses Capital

CenterPoint Energy (CNP)
Abbvie (ABBV)
Knight-swift Transn Hldgs In Cl A (KNX)
Wal-Mart Stores (WMT)
Target Corporation (TGT)
Peoples Ban (PEBO)
Delta Air Lines Com New (DAL)
Astrana Health Com New (ASTH)
SM Energy (SM)
American Superconductor Corp Shs New (AMSC)
Mirum Pharmaceuticals (MIRM)
Arthur J. Gallagher & Co. (AJG)
Wright Express (WEX)
Mosaic (MOS)
Marriott Vacations Wrldwde Cp (VAC)

View all positions for nVerses Capital

Top funds holding Ptc Therapeutics I

BlackRock
Rtw Investments
Jupiter Topco
Henderson Group
Vanguard Portfolio Management
State Street Corporation
Wellington Management Company
Vanguard Capital Management
Geode Capital Management
Toronto-Dominion Bank
Westfield Capital Management Company
Hood River Capital Management
Armistice Capital
William Blair Investment Management
D. E. Shaw & Co

View all funds holding Ptc Therapeutics I